Latham & Watkins represented KKR, while Goodwin Procter advised NetSPI in the transaction. NetSPI, a leader in enterprise penetration testing and attack surface management, announced that...
KKR’s $410 Million Investment in NetSPI
Amgen’s $3.7 Billion Acquisition of ChemoCentryx
Wachtell, Lipton, Rosen & Katz represented Amgen, while Latham & Watkins represented ChemoCentryx in the transaction. Amgen and ChemoCentryx, Inc., a biopharmaceutical company focused on orally...
DigitalBridge Investment Management and IFM’s $11 Billion Take-Private Acquisition of Switch
Latham & Watkins advised the Special Committee of the Board of Directors of Switch, and Simpson Thacher & Bartlett advised DigitalBridge and IFM on the deal....
Chevron’s $3.15 Billion Acquisition of Renewable Energy Group
Paul, Weiss, Rifkind, Wharton & Garrison and Shearman & Sterling represented Chevron, while Latham & Watkins represented Renewable Energy Group in the transaction. Chevron Corporation (NYSE: CVX)...
Oracle’s $28.3 Billion Acquisition of Cerner
Latham & Watkins represented Cerner in the transaction. Hogan Lovells advised Oracle Corporation. Fried Frank acted as counsel to Goldman Sachs and Centerview Partners as financial...
Highgate and Cerberus’ $1.5 Billion Acquisition of CorePoint Lodging
Simpson Thacher represented CorePoint Lodging in the transaction. Kirkland & Ellis and Latham & Watkins advised the joint venture between Cerberus Capital Management, L.P. and affiliates...
Meta’s Acquisition of Within
Cooley LLP advised Within on the deal. Within, a Los Angeles-based firm responsible for developing immersive virtual reality fitness app Supernatural, announced its agreement to sell to...
Tyra Biosciences’ $172.8 Million Initial Public Offering
Latham & Watkins represented Tyra Biosciences in the offering while Sidley advised the underwriters. Tyra Biosciences, Inc. has announced the pricing of its upsized initial public offering of...
Procept BioRobotics’ $163.9 Million Initial Public Offering
Latham & Watkins represented PROCEPT in the transaction. PROCEPT BioRobotics Corporation, a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology,...
Environmental Impact’s Business Combination with GreenLight Biosciences
Foley Hoag represented GreenLight., while Latham & Watkins represented Environmental Impact Acquisition Corp. in the transaction. GreenLight Biosciences, Inc., a biotechnology company dedicated to making ribonucleic acid...
Ginger’s Merger with Headspace
Wilson Sonsini Goodrich & Rosati advised Ginger on the deal, while Latham & Watkins represented Headspace. Ginger, a leading provider of on-demand mental healthcare, and Headspace, a...
Icosavax’s $209.3 Million IPO
Latham & Watkins represented Icosavax, while Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal. Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its...